ZEISS and Concept Life Sciences announce partnership Jena, Germany | ZEISS Research Microscopy Solutions — ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging […]
As fiscal year 2025/26 begins, Carl Zeiss AG is reorganizing its Executive Board under President and CEO Andreas Pecher. Dr. Jochen Peter, responsible for the ZEISS Industrial Quality & Research (IQR) segment, will step down from the Executive Board of Carl Zeiss AG at his own request and on the best of terms on 30 […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan […]
New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture Industry-leading throughput enables real-time analysis of up to six microplates in parallel, maximizing data generation Comprehensive, intuitive workflows with integrated data analysis empower every scientist to generate high-quality data from complex assays with greater speed and confidence Göttingen, Germany […]
Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company’s Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, […]
ZEISS acquires all equity shares of Pi Imaging Technology SA Jena, Germany | ZEISS Research Microscopy Solutions In early July, Carl Zeiss Microscopy GmbH has acquired all equity shares of Pi Imaging Technology SA, based in Lausanne, Switzerland. Pi Imaging Technology SA now operates as “Pi Imaging Technology SA – a ZEISS company”. The Lausanne […]
ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the ZEISS Group. Martin Fischer succeeds Maximilian Foerst, who joined the Executive Board of the ZEISS Group as the President […]
Prof. Dr. Jelena Vučković and Prof. Dr. Yuri Kivshar were honored with the ZEISS Research Award. Oberkochen, Munich / Germany | ZEISS Group Two renowned researchers received the ZEISS Research Award at a ceremony on Thursday evening. The award went to physicists Prof. Dr. Jelena Vučković from Stanford University and Prof. Dr. Yuri Kivshar from […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
